CXCL10 serves to recruit effector T cells expressing CXCR3 to sites of tissue injury; furthermore, inhibition of CXCR3 has been shown to mitigate the severity of GVHD in murine models [166]. This evidence concerns the gene CXCR3 and graft versus host disease.